{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "March 2022: A 36-year-old woman presented to Anhui Chest Hospital with cough and chest pain for 2 months. The patient had no history of smoking.",
        "timestamp": "2022-03",
        "clinical_data": {
          "HPI": [
            {
              "summary": "36-year-old woman presented with cough and chest pain for 2 months.",
              "duration": "2 months",
              "onset": "March 2022",
              "progression": "unknown",
              "associated_symptoms": [
                "C0010200",
                "C0008031"
              ]
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "never"
            }
          ]
        }
      },
      "custom_id": "graph_086_N0"
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "March 21, 2022: Chest computed tomography (CT) revealed left pleural thickening and pleural effusion.",
        "timestamp": "2022-03-21",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Chest",
              "modality": "CT",
              "finding": "left pleural thickening and pleural effusion",
              "date": "2022-03-21"
            }
          ]
        }
      },
      "custom_id": "graph_086_N1"
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Thoracoscopic left pleural biopsy revealed stage IV lung adenocarcinoma. Plasma DNA analysis via next-generation sequencing (NGS) identified EGFR exon L858R (p.Leu858Arg) mutation.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung cancer",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "Thoracoscopic pleural biopsy",
              "approach": "thoracoscopic",
              "location": "left pleura"
            }
          ],
          "labs": [
            {
              "test": "Plasma DNA analysis via next-generation sequencing (NGS)",
              "finding": "EGFR exon L858R (p.Leu858Arg) mutation"
            }
          ]
        }
      },
      "custom_id": "graph_086_N2"
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Patient received osimertinib as the first-line treatment.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705635",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      },
      "custom_id": "graph_086_N3"
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "May 22 2022: Chest CT revealed a partial response (PR).",
        "timestamp": "2022-05-22",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT of chest",
              "body_part": "Thorax",
              "modality": "CT",
              "finding": "Partial response",
              "date": "2022-05-22"
            }
          ]
        }
      },
      "custom_id": "graph_086_N4"
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "April 4 2024: Chest CT revealed progressive disease (PD). Rebiopsy of the lung lesion, and NGS revealed the originally identified EGFR L858R mutation and new BRAF V600E and TP53 mutations.",
        "timestamp": "2024-04-04",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Chest",
              "modality": "CT",
              "finding": "progressive disease (PD)",
              "date": "2024-04-04"
            }
          ],
          "procedures": [
            {
              "name": "Rebiopsy of lung lesion",
              "date": "2024-04-04",
              "location": "Lung"
            }
          ],
          "labs": [
            {
              "test": "NGS",
              "value": "EGFR L858R mutation, BRAF V600E mutation, TP53 mutation",
              "timestamp": "2024-04-04"
            }
          ]
        }
      },
      "custom_id": "graph_086_N5"
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Patient started treatment with dabrafenib and trametinib plus aumolertinib concurrently.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Dabrafenib",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "Trametinib",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "Aumolertinib",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      },
      "custom_id": "graph_086_N6"
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "June 3 2024: Chest CT compared to previous CT (April 4 2024) revealed a complete response (CR).",
        "timestamp": "2024-06-03",
        "clinical_data": {
          "imaging": [
            {
              "type": "363831003",
              "body_part": "Chest",
              "modality": "CT",
              "finding": "complete response",
              "date": "2024-06-03"
            }
          ]
        }
      },
      "custom_id": "graph_086_N7"
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Patient experienced a transient fever with a maximum temperature of 38.5 \u00b0C during treatment with dabrafenib and trametinib plus aumolertinib. Fever was determined to be an adverse reaction to drug therapy.",
        "clinical_data": {
          "vitals": [
            {
              "type": "Fever",
              "value": "38.5",
              "unit": "\u00b0C"
            }
          ],
          "medications": [
            {
              "drug": "dabrafenib",
              "indication": "adverse reaction"
            },
            {
              "drug": "trametinib",
              "indication": "adverse reaction"
            },
            {
              "drug": "aumolertinib",
              "indication": "adverse reaction"
            }
          ],
          "diagnoses": [
            {
              "code": "adverse reaction",
              "label": "adverse reaction to drug therapy",
              "status": "active"
            }
          ]
        }
      },
      "custom_id": "graph_086_N8"
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "From initial presentation with cough and chest pain, the patient underwent chest CT.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0010200",
            "C0008031"
          ],
          "change_type": "other",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_086_N1_N2"
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Following the chest CT showing left pleural thickening and pleural effusion, a thoracoscopic left pleural biopsy was performed, and plasma DNA analysis via NGS was done.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "pleural biopsy"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_086_N2_N3"
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Based on the diagnosis of stage IV lung adenocarcinoma with EGFR exon L858R mutation, the patient was started on first-line treatment.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C34",
            "EGFR exon L858R"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_086_N3_N4"
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Following treatment with osimertinib, a chest CT was performed to assess treatment response.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1705635"
          ],
          "change_type": "other",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_086_N4_N5"
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "After initial partial response to osimertinib, follow-up chest CT revealed progressive disease. Rebiopsy and NGS were performed.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "partial response"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_086_N5_N6"
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Based on the identification of new BRAF V600E and TP53 mutations, the patient's treatment regimen was changed.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "BRAF V600E",
            "TP53"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_086_N6_N7"
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Following treatment with dabrafenib, trametinib, and aumolertinib, a chest CT was performed to assess treatment response.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "dabrafenib",
            "trametinib",
            "aumolertinib"
          ],
          "change_type": "addition",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_086_N7_N8"
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "During treatment with dabrafenib, trametinib, and aumolertinib, the patient experienced a transient fever.",
        "transition_event": {
          "trigger_type": "medication_change"
        }
      },
      "custom_id": "graph_086_N8_N9"
    }
  ]
}